Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis

2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism

(2014)   EUROPEAN HEART JOURNAL

Clinical and Safety Outcomes Associated With Treatment of Acute Venous Thromboembolism

(2014) Lana A. Castellucci et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Indirect comparison of dabigatran, rivaroxaban, apixaban and edoxaban for the treatment of acute venous thromboembolism

(2014) Simon Mantha et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Indirect treatment comparison of new oral anticoagulants for the treatment of acute venous thromboembolism

(2014) Nayon Kang et al.   THROMBOSIS RESEARCH

Incidence of and Mortality from Venous Thromboembolism in a Real-world Population: The Q-VTE Study Cohort

(2013) Vicky Tagalakis et al.   AMERICAN JOURNAL OF MEDICINE

Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis

(2013) Sam Schulman et al.   CIRCULATION

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

(2013) Gary H. Lyman et al.   JOURNAL OF CLINICAL ONCOLOGY

Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis

(2013) T. van der Hulle et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

Oral Apixaban for the Treatment of Acute Venous Thromboembolism

(2013) Giancarlo Agnelli et al.   NEW ENGLAND JOURNAL OF MEDICINE

New oral anticoagulants: A view from the laboratory

(2012) Jeffrey I. Weitz   AMERICAN JOURNAL OF HEMATOLOGY

Oral Anticoagulant Therapy

(2012) Walter Ageno et al.   CHEST

Executive Summary

(2012) Gordon H. Guyatt et al.   CHEST

Antithrombotic Therapy for VTE Disease

(2012) Clive Kearon et al.   CHEST

Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials

(2012) B. D. Fox et al.   BMJ-British Medical Journal

External and internal validity of open label or double-blind trials in oral anticoagulation: better, worse or just different?

(2011) J. BEYER-WESTENDORF et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Economic burden of venous thromboembolism: a systematic review

(2011) Andras Ruppert et al.   JOURNAL OF MEDICAL ECONOMICS

Risk Assessment of Recurrence in Patients With Unprovoked Deep Vein Thrombosis or Pulmonary Embolism

(2010) Sabine Eichinger et al.   CIRCULATION

Major bleeding as a predictor of mortality in patients with venous thromboembolism: findings from the RIETE Registry

(2010) P. PRANDONI et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Venous Thromboembolism

(2009) Tienan Zhu et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Post-thrombotic syndrome: prevalence, prognostication and need for progress

(2009) Paolo Prandoni et al.   BRITISH JOURNAL OF HAEMATOLOGY

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

(2009) Sam Schulman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Economic Burden of Venous Thromboembolism in Hospitalized Patients

(2009) Paul P Dobesh   PHARMACOTHERAPY

Efficacy and safety of the oral direct factorXa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose-ranging study

(2008) et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS